These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4013993)

  • 1. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
    Poser RF; Podrid PJ; Lombardi F; Lown B
    Am Heart J; 1985 Jul; 110(1 Pt 1):9-16. PubMed ID: 4013993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggravation of arrhythmia: a complication of antiarrhythmic drug therapy.
    Podrid PJ
    Eur Heart J; 1989 Sep; 10 Suppl E():66-72. PubMed ID: 2680505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
    Slater W; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1988 Feb; 61(4):349-53. PubMed ID: 3124591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
    Velebit V; Podrid P; Lown B; Cohen BH; Graboys TB
    Circulation; 1982 May; 65(5):886-94. PubMed ID: 6176355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic evaluation of antiarrhythmic drugs.
    Touboul P
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():535-9. PubMed ID: 2275885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can antiarrhythmic drugs cause arrhythmia?
    Podrid PJ
    J Clin Pharmacol; 1984 Jul; 24(7):313-9. PubMed ID: 6480877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of arrhythmia: a complication of antiarrhythmic drugs.
    Podrid PJ
    J Cardiovasc Electrophysiol; 1993 Jun; 4(3):311-9. PubMed ID: 8269302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ease of inducibility of arrhythmia with electrophysiologic testing and response to antiarrhythmic therapy.
    Amann FW; Blatt CM; Podrid PJ; Lown B
    Am Heart J; 1986 Apr; 111(4):625-31. PubMed ID: 3953383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of reproducibility of baseline arrhythmia induction on drug efficacy predictions and outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial.
    Mann DE; Hartz V; Hahn EA; Reiter MJ
    Am J Cardiol; 1997 Dec; 80(11):1448-52. PubMed ID: 9399720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug selection.
    Podrid PJ
    Annu Rev Med; 1987; 38():1-17. PubMed ID: 3555284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents.
    Kudenchuk PJ; Kron J; Walance C; McAnulty JH
    Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proarrhythmia, a serious complication of antiarrhythmic drugs.
    Podrid PJ
    Curr Cardiol Rep; 1999 Nov; 1(4):289-96. PubMed ID: 10980856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.